Archives

• December 2011
• November 2011
• October 2011
• September 2011
• August 2011
• July 2011
• June 2011
• May 2011
• April 2011
• March 2011
• February 2011
• January 2011
• December 2010
• November 2010
• October 2010
• September 2010
• August 2010
• July 2010
• June 2010
• May 2010
• April 2010
• March 2010
• February 2010
• January 2010
• December 2009
• November 2009
• October 2009
• September 2009
• August 2009
• July 2009
• June 2009
• May 2009
• April 2009
• March 2009
• February 2009
• January 2009
• December 2008
• November 2008
• October 2008
• September 2008
• August 2008
• July 2008
• June 2008
• May 2008
• April 2008
• March 2008
• February 2008
• January 2008
• December 2007
• November 2007
• October 2007
• September 2007
• August 2007
• July 2007
• June 2007
• May 2007
• April 2007
• March 2007
• February 2007
• January 2007
• December 2006
• November 2006
• October 2006
• September 2006
• August 2006
• July 2006
• June 2006
• May 2006
• November 2005

Categories

• BJALCF News (233)
• Clinical Trials (5)
• Diagnosis (1)
• Early Detection (373)
• Education (508)
• Legislation (102)
• Mesothelioma (43)
• Molecular/genetic testing (1)
• Non-Small-Cell (331)
• Other News (840)
• Prevention (168)
• Radiation Oncology (2)
• Radon (86)
• Research (3374)
• Small-Cell (77)
• Smoking Cessation (210)
• Support (373)
• Treatment (742)

The role of gefitinib in Asian nonsmokers with lung cancer

September 15th, 2008

The targeted therapy gefitinib should be considered a first-line therapy for non-smoking Asian patients with adenocarcinoma of the lung, one of the most common types of lung cancer, suggests a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.

 

Posted in Research by Debi

Trackback

 

Leave a Reply

© Copyright 2009 Bonnie J Addario Lung Cancer Foundation. All Rights Reserved.

601 4th Street Suite 215 | San Francisco, CA 94107 | 415.357.1278 ph | info@lungcancerfoundation.org